B A Roach1, M J Donahue2, L T Davis1, C C Faraco1, D Arteaga1, S-C Chen3, T R Ladner1, A O Scott1, M K Strother1. 1. From the Departments of Radiology and Radiological Sciences (B.A.R., M.J.D., L.T.D., C.C.F., D.A., T.R.L., A.O.S., M.K.S.). 2. From the Departments of Radiology and Radiological Sciences (B.A.R., M.J.D., L.T.D., C.C.F., D.A., T.R.L., A.O.S., M.K.S.) Neurology (M.J.D.) Psychiatry (M.J.D.) mj.donahue@vanderbilt.edu. 3. the Vanderbilt Center for Quantitative Sciences (S.-C.C.), Vanderbilt Medical Center, Nashville, Tennessee.
Abstract
BACKGROUND AND PURPOSE: The importance of collateralization for maintaining adequate cerebral perfusion is increasingly recognized. However, measuring collateral flow noninvasively has proved elusive. The aim of this study was to assess correlations among baseline perfusion and arterial transit time artifacts, cerebrovascular reactivity, and the presence of collateral vessels on digital subtraction angiography. MATERIALS AND METHODS: The relationship between the presence of collateral vessels on arterial spin-labeling MR imaging and DSA was compared with blood oxygen level-dependent MR imaging measures of hypercapnic cerebrovascular reactivity in patients with symptomatic intracranial stenosis (n = 18). DSA maps were reviewed by a neuroradiologist and assigned the following scores: 1, collaterals to the periphery of the ischemic site; 2, complete irrigation of the ischemic bed via collateral flow; and 3, normal antegrade flow. Arterial spin-labeling maps were scored according to the following: 0, low signal; 1, moderate signal with arterial transit artifacts; 2, high signal with arterial transit artifacts; and 3, normal signal. RESULTS: In regions with normal-to-high signal on arterial spin-labeling, collateral vessel presence on DSA strongly correlated with declines in cerebrovascular reactivity (as measured on blood oxygen level-dependent MR imaging, P < .001), most notably in patients with nonatherosclerotic disease. There was a trend toward increasing cerebrovascular reactivity with increases in the degree of collateralization on DSA (P = .082). CONCLUSIONS: Collateral vessels may have fundamentally different vasoreactivity properties from healthy vessels, a finding that is observed most prominently in nonatherosclerotic disease and, to a lesser extent, in atherosclerotic disease.
BACKGROUND AND PURPOSE: The importance of collateralization for maintaining adequate cerebral perfusion is increasingly recognized. However, measuring collateral flow noninvasively has proved elusive. The aim of this study was to assess correlations among baseline perfusion and arterial transit time artifacts, cerebrovascular reactivity, and the presence of collateral vessels on digital subtraction angiography. MATERIALS AND METHODS: The relationship between the presence of collateral vessels on arterial spin-labeling MR imaging and DSA was compared with blood oxygen level-dependent MR imaging measures of hypercapnic cerebrovascular reactivity in patients with symptomatic intracranial stenosis (n = 18). DSA maps were reviewed by a neuroradiologist and assigned the following scores: 1, collaterals to the periphery of the ischemic site; 2, complete irrigation of the ischemic bed via collateral flow; and 3, normal antegrade flow. Arterial spin-labeling maps were scored according to the following: 0, low signal; 1, moderate signal with arterial transit artifacts; 2, high signal with arterial transit artifacts; and 3, normal signal. RESULTS: In regions with normal-to-high signal on arterial spin-labeling, collateral vessel presence on DSA strongly correlated with declines in cerebrovascular reactivity (as measured on blood oxygen level-dependent MR imaging, P < .001), most notably in patients with nonatherosclerotic disease. There was a trend toward increasing cerebrovascular reactivity with increases in the degree of collateralization on DSA (P = .082). CONCLUSIONS: Collateral vessels may have fundamentally different vasoreactivity properties from healthy vessels, a finding that is observed most prominently in nonatherosclerotic disease and, to a lesser extent, in atherosclerotic disease.
Authors: Reinoud P H Bokkers; Matthias J P van Osch; Catharina J M Klijn; L Jaap Kappelle; Jeroen Hendrikse Journal: J Neurol Neurosurg Psychiatry Date: 2011-03-08 Impact factor: 10.154
Authors: Carlos C Faraco; Megan K Strother; Lindsey M Dethrage; Lori Jordan; Robert Singer; Paul F Clemmons; Manus J Donahue Journal: Magn Reson Med Date: 2014-04-22 Impact factor: 4.668
Authors: Bijoy K Menon; Christopher D d'Esterre; Emmad M Qazi; Mohammed Almekhlafi; Leszek Hahn; Andrew M Demchuk; Mayank Goyal Journal: Radiology Date: 2015-01-29 Impact factor: 11.105
Authors: Manus J Donahue; Carlos C Faraco; Megan K Strother; Michael A Chappell; Swati Rane; Lindsey M Dethrage; Jeroen Hendrikse; Jeroen C W Siero Journal: J Cereb Blood Flow Metab Date: 2014-04-30 Impact factor: 6.200
Authors: Oh Young Bang; Jeffrey L Saver; Suk Jae Kim; Gyeong-Moon Kim; Chin-Sang Chung; Bruce Ovbiagele; Kwang Ho Lee; David S Liebeskind Journal: Stroke Date: 2011-01-13 Impact factor: 7.914
Authors: David Y T Chen; Yosuke Ishii; Audrey P Fan; Jia Guo; Moss Y Zhao; Gary K Steinberg; Greg Zaharchuk Journal: Radiology Date: 2020-07-14 Impact factor: 11.105
Authors: Petrice M Cogswell; Taylor L Davis; Megan K Strother; Carlos C Faraco; Allison O Scott; Lori C Jordan; Matthew R Fusco; Blaise deB Frederick; Jeroen Hendrikse; Manus J Donahue Journal: J Magn Reson Imaging Date: 2017-01-06 Impact factor: 4.813
Authors: Jennifer M Watchmaker; Blaise deB Frederick; Matthew R Fusco; Larry T Davis; Meher R Juttukonda; Sarah K Lants; Howard S Kirshner; Manus J Donahue Journal: Neurosurgery Date: 2019-01-01 Impact factor: 4.654
Authors: Jennifer M Watchmaker; Meher R Juttukonda; Larry T Davis; Allison O Scott; Carlos C Faraco; Melissa C Gindville; Lori C Jordan; Petrice M Cogswell; Angela L Jefferson; Howard S Kirshner; Manus J Donahue Journal: J Cereb Blood Flow Metab Date: 2016-12-28 Impact factor: 6.200
Authors: Skylar E Johnson; Colin D McKnight; Sarah K Lants; Meher R Juttukonda; Matthew Fusco; Rohan Chitale; Paula C Donahue; Daniel O Claassen; Manus J Donahue Journal: J Cereb Blood Flow Metab Date: 2019-09-09 Impact factor: 6.200
Authors: Spencer L Waddle; Meher R Juttukonda; Sarah K Lants; Larry T Davis; Rohan Chitale; Matthew R Fusco; Lori C Jordan; Manus J Donahue Journal: J Cereb Blood Flow Metab Date: 2019-05-08 Impact factor: 6.200
Authors: Ji Young Ha; Young Hun Choi; Seunghyun Lee; Yeon Jin Cho; Jung Eun Cheon; In One Kim; Woo Sun Kim Journal: Korean J Radiol Date: 2019-06 Impact factor: 3.500